You can view the current or previous issues of Diabetes Health online, in their entirety, anytime you want.
Click Here To View
Latest Diabetes Articles
Popular Diabetes Articles
Highly Recommended Diabetes Articles
Send a link to this page to your friends and colleagues.
On May 30, medical-devices maker Medtronic Inc. of Minneapolis agreed to buy insulin-pump maker MiniMed Inc. and Medical Research Group Inc.—a firm partly owned by MiniMed—for $3.7 billion.
Medtronic will pay $48 cash per share for the Northridge, California-based MiniMed, for a total of about $3.28 billion. The remaining $420 million will go toward the purchase of Medical Research Group, which designs and develops implantable pumps and sensors (i.e., an "artificial pancreas").
"MiniMed's market leadership in diabetes management offers immediate opportunities for reaching an expanding market that includes more than 16 million people in the United States,'' said Art Collins, chief executive of Medtronic.
Terrance Gregg, president and chief operating officer of MiniMed told Diabetes Health, "We do not expect our name, or the quality of service we provide to our customers, to change. Rather, we expect our relationship with Medtronic to help us advance our technologies at a faster rate and enable us to provide superior service and responsive clinical support to patients living with diabetes."
Gregg adds that Medtronic will provide MiniMed with the financial muscle necessary to grow even further.
"[This will enable] us to enrich the lives of patients living with diabetes each and every day," says Gregg.
Medtronic expects to complete the acquisitions within four months. Medtronic shares rose 22 cents to $43.17 in May 30 trading on the New York Stock Exchange. MiniMed shares rose $2.97, or 6.8 percent, to $46.97, in trading on the Nasdaq Stock Market.
0 comments - Jul 1, 2001
Diabetes Health is the essential resource for people living with diabetes- both newly diagnosed and experienced as well as the professionals who care for them. We provide balanced expert news and information on living healthfully with diabetes. Each issue includes cutting-edge editorial coverage of new products, research, treatment options, and meaningful lifestyle issues.